<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Ophthalmology Reports</journal-id><journal-title-group><journal-title xml:lang="en">Ophthalmology Reports</journal-title><trans-title-group xml:lang="ru"><trans-title>Офтальмологические ведомости</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1998-7102</issn><issn publication-format="electronic">2412-5423</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">440</article-id><article-id pub-id-type="doi">10.17816/OV2013144-50</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Visual acuity dynamics after phacoemulsification in patients with “wet” form of age-related macular degeneration, treated by intravitreal angiogenesis inhibitor injections</article-title><trans-title-group xml:lang="ru"><trans-title>Динамика остроты зрения у пациентов с «влажной» формой возрастной макулярной дегенерации, получающих интравитреальные инъекции ингибитора ангиогенеза,после факоэмульсификации</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Chistyakova</surname><given-names>Natalya Viktorovna</given-names></name><name xml:lang="ru"><surname>Чистякова</surname><given-names>Наталья Викторовна</given-names></name></name-alternatives><bio xml:lang="en"><p>Department of Ophthalmology</p></bio><bio xml:lang="ru"><p>врач-офтальмолог ИДГиТ им. Р. М. Горбачевой, заочный аспирант кафедры офтальмологии</p></bio><email>nchistik@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Astakhov</surname><given-names>Yuriy Sergeevich</given-names></name><name xml:lang="ru"><surname>Астахов</surname><given-names>Юрий Сергеевич</given-names></name></name-alternatives><bio xml:lang="en"><p>doctor of medical science, professor, head of the department of ophthalmology</p></bio><bio xml:lang="ru"><p>д. м. н., профессор, заведующий кафедрой офтальмологии</p></bio><email>astakhov@spmu.rssi.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Dal</surname><given-names>Nikita Yuryevich</given-names></name><name xml:lang="ru"><surname>Даль</surname><given-names>Никита Юрьевич</given-names></name></name-alternatives><bio xml:lang="en"><p>candidate of medical science, assistant professor, Department of Ophthalmology</p></bio><bio xml:lang="ru"><p>к. м. н., доцент кафедры офтальмологии</p></bio><email>nchistik@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I. P. Pavlov State Medical University</institution></aff><aff><institution xml:lang="ru">СПбГМУ им. акад. И. П. Павлова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2013-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2013</year></pub-date><volume>6</volume><issue>1</issue><issue-title xml:lang="en">VOL 6, NO1 (2013)</issue-title><issue-title xml:lang="ru">ТОМ 6, №1 (2013)</issue-title><fpage>44</fpage><lpage>50</lpage><history><date date-type="received" iso-8601-date="2015-06-24"><day>24</day><month>06</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2013, Chistyakova N.V., Astakhov Y.S., Dal N.Y.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2013, Чистякова Н.В., Астахов Ю.С., Даль Н.Ю.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="en">Chistyakova N.V., Astakhov Y.S., Dal N.Y.</copyright-holder><copyright-holder xml:lang="ru">Чистякова Н.В., Астахов Ю.С., Даль Н.Ю.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2015-06-08"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/ov/article/view/440">https://journals.eco-vector.com/ov/article/view/440</self-uri><abstract xml:lang="en"><p>Design: prospective non-randomized experimental longitudinal cohort study. The aim of the study: to evaluate the visual acuity after phacoemulsification in patients with the “wet” form of age-related macular degeneration, treated by intravitreal angiogenesis inhibitor injections. Materials: 48 patients (48 eyes) with the “wet” form of AMD, treated by intravitreal angiogenesis inhibitor injections, and incipient cataract. All eyes in the study had a diagnosis of “wet” AMD and underwent cataract surgery. They were followed for a minimum of two years after the cataract surgery. The mean age of patients was 78.16 ± 5 years. There were 36 female (75 %) and 12 male (25 %) patients. Results: All patients were retrospectively divided into two groups. Group No. 1 consisted of 23 patients — operated within a year of the diagnosis of “wet” AMD, and group No. 2 which consisted of 25 patients who had a diagnosis of “wet” AMD for longer than one year prior to the cataract surgery. The mean preoperative visual acuity in the 1st group was 0.16 ± 0.07 (median 0.15), and in patients of group 2 — 0.23 ± 0.06 (median 0,2). Mean visual acuity immediately before surgery in the 1st group was 0.13 ± 0.04 (median 0.09), in the 2nd group — 0.12 ± 0.04 (median 0,08). After surgery, in the 1st group, mean visual acuity was — 0.28 ± 0.08 (median 0.25), in the 2nd group —0.18 ± 0.07 (median 0,15). The difference between the two groups was statistically significant, p &lt; 0.01, t-test. Statistically significant visual acuity increase after surgery was registered in both groups and was preserved after one and two years, when compared to the data before surgery: for the 1st group — 0.13 and 0.1; for the 2nd group — 0,1 and 0.07, respectively (p &lt; 0,01, Wilcoxon criterion). Conclusions: Phacoemulsification is reasonable for eyes with the “wet” form of age-related macular degeneration. Patients with shorter “wet” AMD duration obtain a higher visual acuity increase after cataract surgery. Statistically significant visual acuity increase after surgery is preserved in the majority of patients during next 2 years of follow-up.</p></abstract><trans-abstract xml:lang="ru"><p>Дизайн: проспективное нерандомизированное экспериментальное продольное когортное исследование. Цель: оценить динамику остроты зрения после факоэмульсификации у пациентов с «влажной» формой возрастной макулярной дегенерации, получающих интравитреальные инъекции ингибитора ангиогенеза. Материалы: 48 пациентов (48 глаз) с диагнозом «влажная» форма ВМД, получающих интравитреально ингибиторы ангиогенеза, и начальная катаракта. Все исследуемые глаза в ходе лечения ВМД были прооперированы по поводу катаракты и наблюдались после операции в течение 2-х лет. Средний возраст пациентов 78,16 ± 5 лет. Женщины составили 36 человек (75 %), мужчины — 12 человек (25 %). Результаты: Пациенты ретроспективно распределились на две группы в зависимости от сроков факоэмульсификации с момента постановки диагноза и начала лечения «влажной» формы ВМД: 23 человека составили группу № 1 — оперированы до года, 25 человек — группу № 2 — оперированы после года от начала «влажной» формы ВМД. Средняя острота зрения на начало наблюдения у пациентов группы № 1 составила 0,16 ± 0,07, с медианой 0,15, у пациентов группы № 2 — 0,23 ± 0,06, с медианой 0,2. Средняя острота зрения непосредственно перед операцией в группе № 1 — 0,13 ± 0,04, медиана 0,09, в группе № 2 — 0,12 ± 0,04, медиана 0,08. После операции в группе № 1 средняя острота зрения — 0,28 ± 0,08, медиана — 0,25, в группе № 2 — 0,18 ± 0,07, медиана — 0,15 (разница между группами статистически значима, p &lt; 0,01, t-тест). Статистически значимая прибавка по остроте зрения после операции регистрируется в обеих группах и сохраняется через год и два года относительно данных, зарегистрированных перед операцией: для группы № 1 — 0,13 и 0,1; для группы № 2 — 0,1 и 0,07, соответственно (p &lt; 0,01, критерий Уилкоксона). Выводы: Выполнение факоэмульсификации целесообразно на глазах с «влажной» формой возрастной макулярной дегенерации. Пациенты с меньшим «стажем» «влажной» формы ВМД получают большую прибавку по остроте зрения послехирургического лечения катаракты. Статистически значимая прибавка в остроте зрения после операции у большинства пациентов сохраняется в течение последующих 2 лет наблюдения.</p></trans-abstract><kwd-group xml:lang="en"><kwd>age-related macular degeneration</kwd><kwd>cataract surgery</kwd><kwd>visual acuity</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>возрастная макулярная дегенерация</kwd><kwd>хирургия катаракты</kwd><kwd>острота зрения</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Age-Related Eye Disease Study Research Group. Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS report no. 14. // Arch. Ophthalmol. — 2005. — Vol. 123. — P. 1207–1214.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Age-Related Eye Disease Study Research Group. Visual Acuity Outcomes after Cataract Surgery in Patients with Age-Related Macular Degeneration: AREDS report no. 27. // Ophthalmology. — 2009. — Vol. 116. — P. 2093–2100.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Armbrecht A. M., Findlay C., Kaushal S. et al. Is cataract surgery justified in patients with age related macular degeneration? A visual function and quality of life assessment.// Br. J. Ophthalmol. — 2000. — Vol. 84. — P. 1343–1348.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Baratz K. H., Gray D. T., Hodge D. O. et al. Cataract extraction rates in Olmsted County, Minnesota, 1980 through 1994. // Arch. Ophthalmol. — 1997. — Vol. 115. — P. 1441–1446.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Busbee B. G., Brown M. M., Brown G. C., Sharma S. Incremental cost-effectiveness of initial cataract surgery. // Ophthalmology. — 2002. — Vol. 109. — P. 606–612; discussion 612–613.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Chandrasekaran S., Wang J. J., Rochtchina E., Mitchell P. Change in health-related quality of life after cataract surgery in a population-based sample. // Eye. — 2008. — Vol. 22. — P. 479–484.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>De Jong P. T., Lubsen J. The standard gamble between cataract extraction and AMD. // Graefes Arch. Clin. Exp. Ophthalmol. — 2004. — Vol. 242. — P. 103–105.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Freeman E.E., Munoz B., West S.K. et al. Is there an association between cataract surgery and age-related macular degeneration? Data from three opulation-based studies. // Am. J. Ophthalmol. — 2003. — Vol. 135. — P. 849–856.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Javitt J. C., Brenner M. H., Curbow B. et al. Outcomes of cataract surgery: improvement in visual acuity and subjective visual function after surgery in the first, second, and both eyes. // Arch. Ophthalmol. — 1993. — Vol. 111. — P. 686–691.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Klein R., Klein B. E., Linton K. L. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. // Ophthalmology. — 1992. — Vol. 99. — P. 933–943.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Klein B. E., Klein R., Lee K. E. Incidence of age-related cataract over a 10-year interval: the Beaver Dam Eye Study. // Ophthalmology. — 2002. — Vol. 109. — P. 2052–2057.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Klein R., Klein B. E., Knudtson M. D. et al. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. // Ophthalmology. — 2007. — Vol. 114. — P. 253–62.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Lamoureux E. L., Hooper C. Y., Lim L. et al. Impact of cataract surgery on quality of life in patients with early age-related macular degeneration. // Optom. Vis. Sci. — 2007. — Vol. 84. — P. 683–688.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Liu I. Y., White L., LaCroix A. Z. The association of age-related macular degeneration and lens opacities in the aged. // Am. J. Public.Health. — 1989. — Vol. 79. — P. 765–769.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Lundstrom M., Stenevi U., Thorburn W. Outcome of cataract surgery considering the preoperative situation: a study of possible predictors of the functional outcome. // Br. J. Ophthalmol. — 1999. — Vol. 83. — P. 1272–1276.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Lundstrom M., Brege K.G., Floren I. et al. Cataract surgery and quality of life in patients with age related macular degeneration. // Br. J. Ophthalmol. — 2002. — Vol. 86. — P. 1330–1335.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Lundqvist B., Monestam E. Longitudinal changes in subjective and objective visual function 5 years after cataract surgery: Clin Experiment Ophthalmol prospective population-based study. // J. Cataract. Refract. Surg. — 2006. — Vol. 32. — P. 1944–1950.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Mallah M. K., Hart P. M., McClure M. et al. Improvements in measures of vision and self-reported visual function after cataract extraction in patients with late-stage age-related maculopathy. // Optom. Vis. Sci. — 2001. — Vol. 78. — P. 683–688.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Rutkow I. M. Surgical operations in the United States: then (1983) and now (1994). // Arch. Surg. — 1997. — Vol. 132. — P. 983–990.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Schein O. D., Steinberg E. P., Cassard S. D. et al. Predictors of outcome in patients who underwent cataract surgery. // Ophthalmology. — 1995. — Vol. 102. — P. 817–823.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Shuttleworth G. N., Luhishi E. A., Harrad R. A. Do patients with age related maculopathy and cataract benefit from cataract surgery? // Br. J. Ophthalmol. — 1998. — Vol. 82. — P. 611–616.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Tan A. G., Wang J. J., Rochtchina E. et al. Increase in cataract surgery prevalence from 1992–1994 to 1997–2000: analysis of two population cross-sections. // Clin. Experiment. Ophthalmol. — 2004. — Vol. 32. — P. 284–288.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Wang J. J., Foran S., Mitchell P. Age-specific prevalence and causes of bilateral and unilateral visual impairment in older Australians: the Blue Mountains Eye Study. // Clin. Experimen. Ophthalmol. — 2000. — Vol. 28. — P. 268–273.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Wang J. J., Klein R., Smith W. et al. Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies. // Ophthalmology. — 2003. — Vol. 110. — P. 1960–1967.</mixed-citation></ref></ref-list></back></article>
